pills_in_hand

Ohio takes legal action against pharma companies for opioid crisis

June 1, 2017
Medical Communications Ohio, opioid, opioid crisis

If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …

Navigating the challenges of health technology assessment

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …

student_writing

NLS Pharma reveals data on different kind of ADHD treatment

May 31, 2017
Research and Development NLS Pharma, mazindol

Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …

joe-ciaffoni-biogen-750xx2574-1445-0-143

Collegium bring in former Biogen SVP as new COO

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …

shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

fdaoutsideweb

FDA approves first generic versions of Lilly’s ADHD drug

May 31, 2017
Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …

valium_10mg_roche

Evidence of tampering with Valium medication in Australia

May 31, 2017
Medical Communications, Research and Development Roche, valium

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …

novartis_window

Mounting US pricing pressures cutting into quarterly sales, Novartis admits

May 31, 2017
Research and Development, Sales and Marketing Novartis, Sandoz

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …

220399586_ec18abd879_z

MSD allays Irish fears with €280m expansion investment

May 31, 2017
Manufacturing and Production, Research and Development Ireland, MSD

There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …

shutterstock_38078521

Modified antibiotic shows big promise against drug-resistant bacteria

May 30, 2017
Research and Development antibiotic resistance, vancomycin

Scientists at The Scripps Research Institute (TSRI) have succeeded in reengineering vancomycin – a widely-used antibiotic – in order to …

shutterstock_273326141

BMS and Array BioPharma partner up to tackle colorectal cancer

May 30, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb

Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …

Glenmark greenlighted to market hypertension generic in US

May 30, 2017
Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension

Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …

shutterstock_57369385

Beta blockers offer little to no benefit for heart attack patients, study suggests

May 30, 2017
Manufacturing and Production, Research and Development beta-blockers, heart attack

New research from the University of Leeds has called into question the prevalent practice of prescribing beta blockers for heart …

novartis_outside_1

FDA approves Novartis’ Zykadia as first-line lung cancer treatment

May 30, 2017
Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis

The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …

shutterstock_146497481

Gene-editing tool CRISPR found to cause unintentional mutations in live animal models

May 30, 2017
Manufacturing and Production, Research and Development crispr

Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …

Global Pricing Innovations and Pricing360 announce new strategic partnership

May 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …

dr

WHO elects first African Director General

May 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …

pollution

Superbugs in the supply chain

May 26, 2017
Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …

New FDA Commissioner reveals strategy to drive down drug prices

May 26, 2017
Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, Trump, pricing

Deregulation, faster access and cheaper drug prices very quickly became the rallying cry for the Trump administration in the life …

dna

Furore over DNA testing company’s licensing of consumers’ data

May 26, 2017
Medical Communications 23andME, Ancestry, DNA, DNA testing, genetic information

A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …

The Gateway to Local Adoption Series

Latest content